CTXR

Citius Pharmaceuticals Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Contact Info
  • 11 Commerce Drive
  • 1st Floor
  • Cranford, NJ 07016

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001506251
Fiscal Year End 9/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2010
Employees 5 a/o Aug 01, 2016
Company Officers/Contacts
Leonard Mazur Secretary
Myron Holubiak CEO, President
Company Directors
Leonard Mazur Executive Chairman
Suren Dutia
Dr. Eugene Holuka
Dr. William Kane
Howard Safir
Carol Webb
Service Providers
Accounting/Auditing Firm
Wolf & Company, P.C.
99 High Street
Boston, MA, 02110
United States
 
Securities Counsel
Wyrick Robbins Yates & Ponton LLP OTCQX Sponsor
4101 Lake Boone Trail
Suite 300
Raleigh, NC, 27607
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Trail One, Inc. until 9-2014
CTXR Security Details
Share Structure
Market Value1 $36,533,907 a/o Mar 28, 2017
Authorized Shares 200,000,000 a/o Mar 01, 2017
Outstanding Shares 74,558,993 a/o Mar 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 28,666,895 a/o Aug 01, 2016
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 114 a/o Dec 23, 2016
Short Selling Data
Short Interest 8,776 (24.98%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security